United States Department of Justice addresses antitrust issues during COVID-19

The coronavirus epidemic is forcing organizations, especially those in the healthcare field, to collaborate in ways that could violate US antitrust regulations. To head off any violations before they can happen, and to clarify existing and ongoing regulations, the Antitrust Division of the Department of Justice and the Bureau of Competition of the Federal Trade Commission issued a joint statement[1] on the matter.

This document is only available to members. Please log in or become a member.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field